Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Papilloma Virus Vaccine Therapy in Treating Young Patients With Recurrent Papilloma of the Larynx Clinical Trials Information presented on Clinical Trials Search isn't intended to be a substitute for proven healthcare advice, trips or treatment using a real physician. We are not docs. Always confer with your mD on Papilloma Virus Vaccine Therapy in Treating Young Patients With Recurrent Papilloma of the Larynx conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. Papilloma Virus Vaccine Therapy in Treating Young Patients With Recurrent Papilloma of the Larynx Clinical research trials and Papilloma Virus Vaccine Therapy in Treating Young Patients With Recurrent Papilloma of the Larynx medical trials take place in hundreds of localities across the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually measure the effectiveness of new drugs. The intention of the studies / projects is to resolve certain human health questions. Clinical trials are a popular means for physicians, government agencies, and private sector corporations to detect remedies for all forms of circumstances, like Papilloma Virus Vaccine Therapy in Treating Young Patients With Recurrent Papilloma of the Larynx. Papilloma Virus Vaccine Therapy in Treating Young Patients With Recurrent Papilloma of the Larynx Clinical Trials and other clinical trials allow for volunteers to undergo healthcare treatment options before they are available to the masses. Most times the participants receive treatment for free, and every now and again they are paid for their time. Occasionally there is a cost for a Papilloma Virus Vaccine Therapy in Treating Young Patients With Recurrent Papilloma of the Larynx clinical trial. Subjects typically recieve the finest healthcare available for their Papilloma Virus Vaccine Therapy in Treating Young Patients With Recurrent Papilloma of the Larynx condition. Hazards are a reality, nonetheless, and might include more or frequent mD trips, health risks (potentially life-endangering), and/or the treatment being ineffective. Trials are federally regulated with stern guidelines to protect clinical trials subjects.

Home > "P" Clinical Trials Conditions > Papilloma Virus Vaccine Therapy in Treating Young Patients With Recurrent Papilloma of the Larynx

Papilloma Virus Vaccine Therapy in Treating Young Patients With Recurrent Papilloma of the Larynx



Papilloma Virus Vaccine Therapy in Treating Young Patients With Recurrent Papilloma of the Larynx

For Condition: respiratory papillomas
Status: No longer recruiting
Sponsor(s): New Jersey Medical School ,
Synopsis: RATIONALE: Vaccines made from papilloma virus cells may make the body build an immune response to and kill papilloma cells. PURPOSE: Phase II trial to study the effectiveness of papilloma virus vaccine in treating young patients with recurrent papilloma of the larynx.
Details: OBJECTIVES: I. Determine the immune response in patients with juvenile papilloma of the larynx treated with autogenous vaccine derived from each patient's own tumor. PROTOCOL OUTLINE: Patients receive autogenous papilloma vaccine intradermally and subcutaneously weekly for 20 weeks. PROJECTED ACCRUAL: Not specified
Eligibility:
Study Type:
  Interventional, Treatment
Minimum Age/Maximum Age: 1 Year/
Genders: 
Protocol Entry Criteria: PROTOCOL ENTRY CRITERIA: --Disease Characteristics-- - Diagnosis of severe recurrent juvenile papilloma of the larynx requiring surgery at least 4 times per year; Condition must have existed for more than 1 year --Prior/Concurrent Therapy-- - See Disease Characteristics --Patient Characteristics-- - Age: 1 year and over - Performance status: Not specified - Life expectancy: Not specified - Hematopoietic: Not specified - Hepatic: Not specified - Renal: Not specified
Total Enrollment: 

Location and Contact Information:

Overall Study Official:
JamesOleske,  Study Chair,  New Jersey Medical School

New Jersey Medical School
Newark,  New Jersey,  07103-2714
United States
 


Additional Information:
Study ID Numbers:
  CDR0000071657;  NJ-LAR-1,NJ-M-41-1976
Study Start Date: December 1971
Record last reviewed: February 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00002454

Other Respiratory Papillomas Studies:
1. Papilloma Virus Vaccine Therapy in Treating Young Patients With Recurrent Papilloma of the Larynx

Related Studies:

Other respiratory papillomas Clinical Trials
Other New Jersey Clinical Trials
Other Newark Clinical Trials

Papilloma Virus Vaccine Therapy in Treating Young Patients With Recurrent Papilloma of the Larynx

Modify your Search

  Other respiratory papillomas Clinical Trials
  Other New Jersey Clinical Trials
  Other Newark Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103